nodes	percent_of_prediction	percent_of_DWPC	metapath
Lansoprazole—MAPT—Docetaxel—stomach cancer	0.282	0.46	CbGbCtD
Lansoprazole—CYP1B1—Docetaxel—stomach cancer	0.0447	0.0729	CbGbCtD
Lansoprazole—ABCB1—Mitomycin—stomach cancer	0.0407	0.0665	CbGbCtD
Lansoprazole—CYP1B1—Doxorubicin—stomach cancer	0.0333	0.0544	CbGbCtD
Lansoprazole—ABCG2—Irinotecan—stomach cancer	0.029	0.0473	CbGbCtD
Lansoprazole—ABCG2—Fluorouracil—stomach cancer	0.0278	0.0454	CbGbCtD
Lansoprazole—ATP4A—gastric juice—stomach cancer	0.025	0.351	CbGeAlD
Lansoprazole—ABCG2—Docetaxel—stomach cancer	0.0212	0.0347	CbGbCtD
Lansoprazole—CYP2C9—Capecitabine—stomach cancer	0.0174	0.0284	CbGbCtD
Lansoprazole—ABCG2—Doxorubicin—stomach cancer	0.0158	0.0258	CbGbCtD
Lansoprazole—ABCG2—Methotrexate—stomach cancer	0.0153	0.025	CbGbCtD
Lansoprazole—CYP2C8—Fluorouracil—stomach cancer	0.0148	0.0242	CbGbCtD
Lansoprazole—CYP1A2—Fluorouracil—stomach cancer	0.0115	0.0187	CbGbCtD
Lansoprazole—ABCB1—Irinotecan—stomach cancer	0.0104	0.0171	CbGbCtD
Lansoprazole—CYP2C9—Fluorouracil—stomach cancer	0.0103	0.0169	CbGbCtD
Lansoprazole—ABCB1—Docetaxel—stomach cancer	0.00765	0.0125	CbGbCtD
Lansoprazole—CYP3A4—Irinotecan—stomach cancer	0.00626	0.0102	CbGbCtD
Lansoprazole—ABCB1—Doxorubicin—stomach cancer	0.00571	0.00932	CbGbCtD
Lansoprazole—ABCB1—Methotrexate—stomach cancer	0.00553	0.00902	CbGbCtD
Lansoprazole—CYP2D6—Doxorubicin—stomach cancer	0.00538	0.00878	CbGbCtD
Lansoprazole—CYP3A4—Docetaxel—stomach cancer	0.00459	0.00749	CbGbCtD
Lansoprazole—ATP4B—digestive system—stomach cancer	0.00351	0.0492	CbGeAlD
Lansoprazole—CYP3A4—Doxorubicin—stomach cancer	0.00342	0.00558	CbGbCtD
Lansoprazole—ATP4B—endocrine gland—stomach cancer	0.0029	0.0407	CbGeAlD
Lansoprazole—ATP4B—liver—stomach cancer	0.00261	0.0367	CbGeAlD
Lansoprazole—ATP4A—hematopoietic system—stomach cancer	0.0022	0.0308	CbGeAlD
Lansoprazole—ATP4A—epithelium—stomach cancer	0.00201	0.0282	CbGeAlD
Lansoprazole—CYP4A11—digestive system—stomach cancer	0.00189	0.0266	CbGeAlD
Lansoprazole—CYP4A11—endocrine gland—stomach cancer	0.00157	0.022	CbGeAlD
Lansoprazole—ATP4A—digestive system—stomach cancer	0.00153	0.0214	CbGeAlD
Lansoprazole—CYP4A11—liver—stomach cancer	0.00141	0.0198	CbGeAlD
Lansoprazole—ATP4A—endocrine gland—stomach cancer	0.00126	0.0177	CbGeAlD
Lansoprazole—CYP2C18—digestive system—stomach cancer	0.00126	0.0176	CbGeAlD
Lansoprazole—MAPT—lymph node—stomach cancer	0.00118	0.0165	CbGeAlD
Lansoprazole—ATP4A—liver—stomach cancer	0.00114	0.016	CbGeAlD
Lansoprazole—CYP2C18—endocrine gland—stomach cancer	0.00104	0.0146	CbGeAlD
Lansoprazole—CYP2C18—liver—stomach cancer	0.000935	0.0131	CbGeAlD
Lansoprazole—CYP1B1—hematopoietic system—stomach cancer	0.000874	0.0123	CbGeAlD
Lansoprazole—CYP1B1—smooth muscle tissue—stomach cancer	0.00077	0.0108	CbGeAlD
Lansoprazole—CYP2C19—hematopoietic system—stomach cancer	0.000767	0.0108	CbGeAlD
Lansoprazole—CYP2C8—hematopoietic system—stomach cancer	0.00067	0.0094	CbGeAlD
Lansoprazole—CYP1A2—hematopoietic system—stomach cancer	0.000627	0.00879	CbGeAlD
Lansoprazole—CYP1A1—hematopoietic system—stomach cancer	0.000618	0.00867	CbGeAlD
Lansoprazole—CYP1B1—lymphoid tissue—stomach cancer	0.000616	0.00864	CbGeAlD
Lansoprazole—CYP1B1—digestive system—stomach cancer	0.000608	0.00853	CbGeAlD
Lansoprazole—ABCB1—blood vessel—stomach cancer	0.000603	0.00846	CbGeAlD
Lansoprazole—CYP2C9—hematopoietic system—stomach cancer	0.000595	0.00835	CbGeAlD
Lansoprazole—CYP1A1—epithelium—stomach cancer	0.000565	0.00793	CbGeAlD
Lansoprazole—CYP2C19—digestive system—stomach cancer	0.000534	0.00749	CbGeAlD
Lansoprazole—CYP1B1—endocrine gland—stomach cancer	0.000502	0.00705	CbGeAlD
Lansoprazole—CYP3A4—hematopoietic system—stomach cancer	0.000454	0.00636	CbGeAlD
Lansoprazole—CYP1B1—liver—stomach cancer	0.000453	0.00636	CbGeAlD
Lansoprazole—CYP2D6—hematopoietic system—stomach cancer	0.000446	0.00626	CbGeAlD
Lansoprazole—CYP2C19—endocrine gland—stomach cancer	0.000441	0.00619	CbGeAlD
Lansoprazole—CYP1A2—digestive system—stomach cancer	0.000436	0.00612	CbGeAlD
Lansoprazole—CYP1A1—digestive system—stomach cancer	0.00043	0.00603	CbGeAlD
Lansoprazole—ABCG2—bone marrow—stomach cancer	0.000417	0.00586	CbGeAlD
Lansoprazole—CYP2C9—digestive system—stomach cancer	0.000414	0.0058	CbGeAlD
Lansoprazole—CYP2C19—liver—stomach cancer	0.000397	0.00558	CbGeAlD
Lansoprazole—CYP2C8—endocrine gland—stomach cancer	0.000385	0.0054	CbGeAlD
Lansoprazole—CYP1A2—endocrine gland—stomach cancer	0.00036	0.00505	CbGeAlD
Lansoprazole—CYP1A1—endocrine gland—stomach cancer	0.000355	0.00498	CbGeAlD
Lansoprazole—CYP1B1—lymph node—stomach cancer	0.000347	0.00487	CbGeAlD
Lansoprazole—CYP2C8—liver—stomach cancer	0.000347	0.00487	CbGeAlD
Lansoprazole—CYP2C9—endocrine gland—stomach cancer	0.000342	0.0048	CbGeAlD
Lansoprazole—ABCG2—liver—stomach cancer	0.000337	0.00473	CbGeAlD
Lansoprazole—CYP1A2—liver—stomach cancer	0.000325	0.00456	CbGeAlD
Lansoprazole—ABCB1—hematopoietic system—stomach cancer	0.000321	0.00451	CbGeAlD
Lansoprazole—CYP1A1—liver—stomach cancer	0.00032	0.00449	CbGeAlD
Lansoprazole—CYP3A4—digestive system—stomach cancer	0.000315	0.00443	CbGeAlD
Lansoprazole—CYP2D6—digestive system—stomach cancer	0.00031	0.00436	CbGeAlD
Lansoprazole—CYP2C9—liver—stomach cancer	0.000308	0.00432	CbGeAlD
Lansoprazole—ABCB1—epithelium—stomach cancer	0.000293	0.00412	CbGeAlD
Lansoprazole—ABCB1—pancreas—stomach cancer	0.000261	0.00367	CbGeAlD
Lansoprazole—CYP3A4—endocrine gland—stomach cancer	0.000261	0.00366	CbGeAlD
Lansoprazole—ABCG2—lymph node—stomach cancer	0.000259	0.00363	CbGeAlD
Lansoprazole—CYP2D6—endocrine gland—stomach cancer	0.000256	0.0036	CbGeAlD
Lansoprazole—CYP1A1—lymph node—stomach cancer	0.000246	0.00345	CbGeAlD
Lansoprazole—CYP3A4—liver—stomach cancer	0.000235	0.0033	CbGeAlD
Lansoprazole—CYP2D6—liver—stomach cancer	0.000231	0.00325	CbGeAlD
Lansoprazole—ABCB1—lymphoid tissue—stomach cancer	0.000226	0.00317	CbGeAlD
Lansoprazole—ABCB1—digestive system—stomach cancer	0.000223	0.00313	CbGeAlD
Lansoprazole—ABCB1—bone marrow—stomach cancer	0.000206	0.00289	CbGeAlD
Lansoprazole—ABCB1—endocrine gland—stomach cancer	0.000184	0.00259	CbGeAlD
Lansoprazole—ABCB1—liver—stomach cancer	0.000166	0.00233	CbGeAlD
Lansoprazole—ABCB1—lymph node—stomach cancer	0.000128	0.00179	CbGeAlD
Lansoprazole—Pharyngitis—Doxorubicin—stomach cancer	6.42e-05	0.000307	CcSEcCtD
Lansoprazole—Paraesthesia—Capecitabine—stomach cancer	6.4e-05	0.000306	CcSEcCtD
Lansoprazole—Decreased appetite—Docetaxel—stomach cancer	6.4e-05	0.000306	CcSEcCtD
Lansoprazole—Headache—Fluorouracil—stomach cancer	6.39e-05	0.000306	CcSEcCtD
Lansoprazole—Urinary tract disorder—Doxorubicin—stomach cancer	6.38e-05	0.000306	CcSEcCtD
Lansoprazole—Oedema peripheral—Doxorubicin—stomach cancer	6.37e-05	0.000305	CcSEcCtD
Lansoprazole—Dysgeusia—Methotrexate—stomach cancer	6.36e-05	0.000305	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Docetaxel—stomach cancer	6.35e-05	0.000304	CcSEcCtD
Lansoprazole—Connective tissue disorder—Doxorubicin—stomach cancer	6.35e-05	0.000304	CcSEcCtD
Lansoprazole—Dyspnoea—Capecitabine—stomach cancer	6.35e-05	0.000304	CcSEcCtD
Lansoprazole—Fatigue—Docetaxel—stomach cancer	6.34e-05	0.000304	CcSEcCtD
Lansoprazole—Angiopathy—Epirubicin—stomach cancer	6.34e-05	0.000304	CcSEcCtD
Lansoprazole—Urethral disorder—Doxorubicin—stomach cancer	6.34e-05	0.000303	CcSEcCtD
Lansoprazole—Nausea—Irinotecan—stomach cancer	6.32e-05	0.000303	CcSEcCtD
Lansoprazole—Immune system disorder—Epirubicin—stomach cancer	6.31e-05	0.000302	CcSEcCtD
Lansoprazole—Mediastinal disorder—Epirubicin—stomach cancer	6.3e-05	0.000302	CcSEcCtD
Lansoprazole—Pain—Docetaxel—stomach cancer	6.29e-05	0.000301	CcSEcCtD
Lansoprazole—Constipation—Docetaxel—stomach cancer	6.29e-05	0.000301	CcSEcCtD
Lansoprazole—Back pain—Methotrexate—stomach cancer	6.29e-05	0.000301	CcSEcCtD
Lansoprazole—Dyspepsia—Capecitabine—stomach cancer	6.27e-05	0.0003	CcSEcCtD
Lansoprazole—Chills—Epirubicin—stomach cancer	6.27e-05	0.0003	CcSEcCtD
Lansoprazole—Arrhythmia—Epirubicin—stomach cancer	6.24e-05	0.000299	CcSEcCtD
Lansoprazole—Visual impairment—Doxorubicin—stomach cancer	6.23e-05	0.000298	CcSEcCtD
Lansoprazole—Decreased appetite—Capecitabine—stomach cancer	6.19e-05	0.000297	CcSEcCtD
Lansoprazole—Alopecia—Epirubicin—stomach cancer	6.17e-05	0.000296	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Capecitabine—stomach cancer	6.15e-05	0.000295	CcSEcCtD
Lansoprazole—Fatigue—Capecitabine—stomach cancer	6.14e-05	0.000294	CcSEcCtD
Lansoprazole—Vision blurred—Methotrexate—stomach cancer	6.13e-05	0.000293	CcSEcCtD
Lansoprazole—Mental disorder—Epirubicin—stomach cancer	6.12e-05	0.000293	CcSEcCtD
Lansoprazole—Erythema multiforme—Doxorubicin—stomach cancer	6.11e-05	0.000293	CcSEcCtD
Lansoprazole—Pain—Capecitabine—stomach cancer	6.09e-05	0.000292	CcSEcCtD
Lansoprazole—Constipation—Capecitabine—stomach cancer	6.09e-05	0.000292	CcSEcCtD
Lansoprazole—Erythema—Epirubicin—stomach cancer	6.08e-05	0.000291	CcSEcCtD
Lansoprazole—Malnutrition—Epirubicin—stomach cancer	6.08e-05	0.000291	CcSEcCtD
Lansoprazole—Feeling abnormal—Docetaxel—stomach cancer	6.06e-05	0.00029	CcSEcCtD
Lansoprazole—Nausea—Fluorouracil—stomach cancer	6.06e-05	0.00029	CcSEcCtD
Lansoprazole—Eye disorder—Doxorubicin—stomach cancer	6.04e-05	0.000289	CcSEcCtD
Lansoprazole—Ill-defined disorder—Methotrexate—stomach cancer	6.03e-05	0.000289	CcSEcCtD
Lansoprazole—Tinnitus—Doxorubicin—stomach cancer	6.03e-05	0.000289	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Docetaxel—stomach cancer	6.02e-05	0.000288	CcSEcCtD
Lansoprazole—Anaemia—Methotrexate—stomach cancer	6.01e-05	0.000288	CcSEcCtD
Lansoprazole—Cardiac disorder—Doxorubicin—stomach cancer	6e-05	0.000287	CcSEcCtD
Lansoprazole—Flatulence—Epirubicin—stomach cancer	5.99e-05	0.000287	CcSEcCtD
Lansoprazole—Tension—Epirubicin—stomach cancer	5.97e-05	0.000286	CcSEcCtD
Lansoprazole—Dysgeusia—Epirubicin—stomach cancer	5.96e-05	0.000285	CcSEcCtD
Lansoprazole—Nervousness—Epirubicin—stomach cancer	5.91e-05	0.000283	CcSEcCtD
Lansoprazole—Back pain—Epirubicin—stomach cancer	5.88e-05	0.000282	CcSEcCtD
Lansoprazole—Feeling abnormal—Capecitabine—stomach cancer	5.87e-05	0.000281	CcSEcCtD
Lansoprazole—Angiopathy—Doxorubicin—stomach cancer	5.87e-05	0.000281	CcSEcCtD
Lansoprazole—Malaise—Methotrexate—stomach cancer	5.86e-05	0.000281	CcSEcCtD
Lansoprazole—Muscle spasms—Epirubicin—stomach cancer	5.85e-05	0.00028	CcSEcCtD
Lansoprazole—Immune system disorder—Doxorubicin—stomach cancer	5.84e-05	0.00028	CcSEcCtD
Lansoprazole—Vertigo—Methotrexate—stomach cancer	5.84e-05	0.00028	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Capecitabine—stomach cancer	5.83e-05	0.000279	CcSEcCtD
Lansoprazole—Mediastinal disorder—Doxorubicin—stomach cancer	5.83e-05	0.000279	CcSEcCtD
Lansoprazole—Abdominal pain—Docetaxel—stomach cancer	5.82e-05	0.000279	CcSEcCtD
Lansoprazole—Body temperature increased—Docetaxel—stomach cancer	5.82e-05	0.000279	CcSEcCtD
Lansoprazole—Leukopenia—Methotrexate—stomach cancer	5.82e-05	0.000279	CcSEcCtD
Lansoprazole—Chills—Doxorubicin—stomach cancer	5.8e-05	0.000278	CcSEcCtD
Lansoprazole—Arrhythmia—Doxorubicin—stomach cancer	5.78e-05	0.000277	CcSEcCtD
Lansoprazole—Vision blurred—Epirubicin—stomach cancer	5.73e-05	0.000274	CcSEcCtD
Lansoprazole—Alopecia—Doxorubicin—stomach cancer	5.71e-05	0.000274	CcSEcCtD
Lansoprazole—Cough—Methotrexate—stomach cancer	5.67e-05	0.000272	CcSEcCtD
Lansoprazole—Mental disorder—Doxorubicin—stomach cancer	5.66e-05	0.000271	CcSEcCtD
Lansoprazole—Urticaria—Capecitabine—stomach cancer	5.66e-05	0.000271	CcSEcCtD
Lansoprazole—Ill-defined disorder—Epirubicin—stomach cancer	5.64e-05	0.00027	CcSEcCtD
Lansoprazole—Abdominal pain—Capecitabine—stomach cancer	5.63e-05	0.00027	CcSEcCtD
Lansoprazole—Body temperature increased—Capecitabine—stomach cancer	5.63e-05	0.00027	CcSEcCtD
Lansoprazole—Convulsion—Methotrexate—stomach cancer	5.63e-05	0.00027	CcSEcCtD
Lansoprazole—Erythema—Doxorubicin—stomach cancer	5.63e-05	0.000269	CcSEcCtD
Lansoprazole—Malnutrition—Doxorubicin—stomach cancer	5.63e-05	0.000269	CcSEcCtD
Lansoprazole—Anaemia—Epirubicin—stomach cancer	5.62e-05	0.000269	CcSEcCtD
Lansoprazole—Agitation—Epirubicin—stomach cancer	5.59e-05	0.000268	CcSEcCtD
Lansoprazole—Flatulence—Doxorubicin—stomach cancer	5.55e-05	0.000266	CcSEcCtD
Lansoprazole—Chest pain—Methotrexate—stomach cancer	5.53e-05	0.000265	CcSEcCtD
Lansoprazole—Arthralgia—Methotrexate—stomach cancer	5.53e-05	0.000265	CcSEcCtD
Lansoprazole—Myalgia—Methotrexate—stomach cancer	5.53e-05	0.000265	CcSEcCtD
Lansoprazole—Tension—Doxorubicin—stomach cancer	5.52e-05	0.000264	CcSEcCtD
Lansoprazole—Dysgeusia—Doxorubicin—stomach cancer	5.51e-05	0.000264	CcSEcCtD
Lansoprazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	5.5e-05	0.000263	CcSEcCtD
Lansoprazole—Malaise—Epirubicin—stomach cancer	5.48e-05	0.000263	CcSEcCtD
Lansoprazole—Discomfort—Methotrexate—stomach cancer	5.47e-05	0.000262	CcSEcCtD
Lansoprazole—Nervousness—Doxorubicin—stomach cancer	5.47e-05	0.000262	CcSEcCtD
Lansoprazole—Vertigo—Epirubicin—stomach cancer	5.46e-05	0.000262	CcSEcCtD
Lansoprazole—Syncope—Epirubicin—stomach cancer	5.45e-05	0.000261	CcSEcCtD
Lansoprazole—Leukopenia—Epirubicin—stomach cancer	5.44e-05	0.000261	CcSEcCtD
Lansoprazole—Back pain—Doxorubicin—stomach cancer	5.44e-05	0.000261	CcSEcCtD
Lansoprazole—Hypersensitivity—Docetaxel—stomach cancer	5.42e-05	0.00026	CcSEcCtD
Lansoprazole—Muscle spasms—Doxorubicin—stomach cancer	5.41e-05	0.000259	CcSEcCtD
Lansoprazole—Palpitations—Epirubicin—stomach cancer	5.37e-05	0.000257	CcSEcCtD
Lansoprazole—Confusional state—Methotrexate—stomach cancer	5.35e-05	0.000256	CcSEcCtD
Lansoprazole—Loss of consciousness—Epirubicin—stomach cancer	5.35e-05	0.000256	CcSEcCtD
Lansoprazole—Cough—Epirubicin—stomach cancer	5.31e-05	0.000254	CcSEcCtD
Lansoprazole—Anaphylactic shock—Methotrexate—stomach cancer	5.3e-05	0.000254	CcSEcCtD
Lansoprazole—Vision blurred—Doxorubicin—stomach cancer	5.3e-05	0.000254	CcSEcCtD
Lansoprazole—Asthenia—Docetaxel—stomach cancer	5.28e-05	0.000253	CcSEcCtD
Lansoprazole—Convulsion—Epirubicin—stomach cancer	5.27e-05	0.000252	CcSEcCtD
Lansoprazole—Infection—Methotrexate—stomach cancer	5.27e-05	0.000252	CcSEcCtD
Lansoprazole—Hypertension—Epirubicin—stomach cancer	5.25e-05	0.000251	CcSEcCtD
Lansoprazole—Hypersensitivity—Capecitabine—stomach cancer	5.25e-05	0.000251	CcSEcCtD
Lansoprazole—Ill-defined disorder—Doxorubicin—stomach cancer	5.22e-05	0.00025	CcSEcCtD
Lansoprazole—Pruritus—Docetaxel—stomach cancer	5.21e-05	0.000249	CcSEcCtD
Lansoprazole—Nervous system disorder—Methotrexate—stomach cancer	5.2e-05	0.000249	CcSEcCtD
Lansoprazole—Anaemia—Doxorubicin—stomach cancer	5.2e-05	0.000249	CcSEcCtD
Lansoprazole—Thrombocytopenia—Methotrexate—stomach cancer	5.19e-05	0.000249	CcSEcCtD
Lansoprazole—Chest pain—Epirubicin—stomach cancer	5.18e-05	0.000248	CcSEcCtD
Lansoprazole—Arthralgia—Epirubicin—stomach cancer	5.18e-05	0.000248	CcSEcCtD
Lansoprazole—Myalgia—Epirubicin—stomach cancer	5.18e-05	0.000248	CcSEcCtD
Lansoprazole—Agitation—Doxorubicin—stomach cancer	5.17e-05	0.000248	CcSEcCtD
Lansoprazole—Anxiety—Epirubicin—stomach cancer	5.16e-05	0.000247	CcSEcCtD
Lansoprazole—Skin disorder—Methotrexate—stomach cancer	5.15e-05	0.000247	CcSEcCtD
Lansoprazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	5.14e-05	0.000246	CcSEcCtD
Lansoprazole—Hyperhidrosis—Methotrexate—stomach cancer	5.13e-05	0.000246	CcSEcCtD
Lansoprazole—Discomfort—Epirubicin—stomach cancer	5.12e-05	0.000245	CcSEcCtD
Lansoprazole—Asthenia—Capecitabine—stomach cancer	5.11e-05	0.000245	CcSEcCtD
Lansoprazole—Malaise—Doxorubicin—stomach cancer	5.07e-05	0.000243	CcSEcCtD
Lansoprazole—Dry mouth—Epirubicin—stomach cancer	5.06e-05	0.000242	CcSEcCtD
Lansoprazole—Vertigo—Doxorubicin—stomach cancer	5.06e-05	0.000242	CcSEcCtD
Lansoprazole—Anorexia—Methotrexate—stomach cancer	5.06e-05	0.000242	CcSEcCtD
Lansoprazole—Syncope—Doxorubicin—stomach cancer	5.05e-05	0.000242	CcSEcCtD
Lansoprazole—Pruritus—Capecitabine—stomach cancer	5.04e-05	0.000241	CcSEcCtD
Lansoprazole—Leukopenia—Doxorubicin—stomach cancer	5.04e-05	0.000241	CcSEcCtD
Lansoprazole—Diarrhoea—Docetaxel—stomach cancer	5.04e-05	0.000241	CcSEcCtD
Lansoprazole—Confusional state—Epirubicin—stomach cancer	5.01e-05	0.00024	CcSEcCtD
Lansoprazole—Palpitations—Doxorubicin—stomach cancer	4.97e-05	0.000238	CcSEcCtD
Lansoprazole—Anaphylactic shock—Epirubicin—stomach cancer	4.96e-05	0.000238	CcSEcCtD
Lansoprazole—Oedema—Epirubicin—stomach cancer	4.96e-05	0.000238	CcSEcCtD
Lansoprazole—Hypotension—Methotrexate—stomach cancer	4.96e-05	0.000237	CcSEcCtD
Lansoprazole—Loss of consciousness—Doxorubicin—stomach cancer	4.95e-05	0.000237	CcSEcCtD
Lansoprazole—Infection—Epirubicin—stomach cancer	4.93e-05	0.000236	CcSEcCtD
Lansoprazole—Cough—Doxorubicin—stomach cancer	4.91e-05	0.000235	CcSEcCtD
Lansoprazole—Shock—Epirubicin—stomach cancer	4.88e-05	0.000234	CcSEcCtD
Lansoprazole—Convulsion—Doxorubicin—stomach cancer	4.88e-05	0.000233	CcSEcCtD
Lansoprazole—Diarrhoea—Capecitabine—stomach cancer	4.88e-05	0.000233	CcSEcCtD
Lansoprazole—Nervous system disorder—Epirubicin—stomach cancer	4.87e-05	0.000233	CcSEcCtD
Lansoprazole—Dizziness—Docetaxel—stomach cancer	4.87e-05	0.000233	CcSEcCtD
Lansoprazole—Thrombocytopenia—Epirubicin—stomach cancer	4.86e-05	0.000233	CcSEcCtD
Lansoprazole—Hypertension—Doxorubicin—stomach cancer	4.86e-05	0.000233	CcSEcCtD
Lansoprazole—Tachycardia—Epirubicin—stomach cancer	4.84e-05	0.000232	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Methotrexate—stomach cancer	4.83e-05	0.000231	CcSEcCtD
Lansoprazole—Skin disorder—Epirubicin—stomach cancer	4.82e-05	0.000231	CcSEcCtD
Lansoprazole—Hyperhidrosis—Epirubicin—stomach cancer	4.8e-05	0.00023	CcSEcCtD
Lansoprazole—Insomnia—Methotrexate—stomach cancer	4.8e-05	0.00023	CcSEcCtD
Lansoprazole—Arthralgia—Doxorubicin—stomach cancer	4.79e-05	0.000229	CcSEcCtD
Lansoprazole—Myalgia—Doxorubicin—stomach cancer	4.79e-05	0.000229	CcSEcCtD
Lansoprazole—Chest pain—Doxorubicin—stomach cancer	4.79e-05	0.000229	CcSEcCtD
Lansoprazole—Anxiety—Doxorubicin—stomach cancer	4.77e-05	0.000229	CcSEcCtD
Lansoprazole—Paraesthesia—Methotrexate—stomach cancer	4.76e-05	0.000228	CcSEcCtD
Lansoprazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	4.76e-05	0.000228	CcSEcCtD
Lansoprazole—Discomfort—Doxorubicin—stomach cancer	4.73e-05	0.000227	CcSEcCtD
Lansoprazole—Anorexia—Epirubicin—stomach cancer	4.73e-05	0.000227	CcSEcCtD
Lansoprazole—Dyspnoea—Methotrexate—stomach cancer	4.73e-05	0.000226	CcSEcCtD
Lansoprazole—Somnolence—Methotrexate—stomach cancer	4.72e-05	0.000226	CcSEcCtD
Lansoprazole—Dizziness—Capecitabine—stomach cancer	4.71e-05	0.000226	CcSEcCtD
Lansoprazole—Dry mouth—Doxorubicin—stomach cancer	4.69e-05	0.000224	CcSEcCtD
Lansoprazole—Vomiting—Docetaxel—stomach cancer	4.68e-05	0.000224	CcSEcCtD
Lansoprazole—Dyspepsia—Methotrexate—stomach cancer	4.67e-05	0.000224	CcSEcCtD
Lansoprazole—Rash—Docetaxel—stomach cancer	4.64e-05	0.000222	CcSEcCtD
Lansoprazole—Hypotension—Epirubicin—stomach cancer	4.64e-05	0.000222	CcSEcCtD
Lansoprazole—Dermatitis—Docetaxel—stomach cancer	4.64e-05	0.000222	CcSEcCtD
Lansoprazole—Confusional state—Doxorubicin—stomach cancer	4.63e-05	0.000222	CcSEcCtD
Lansoprazole—Decreased appetite—Methotrexate—stomach cancer	4.61e-05	0.000221	CcSEcCtD
Lansoprazole—Headache—Docetaxel—stomach cancer	4.61e-05	0.000221	CcSEcCtD
Lansoprazole—Oedema—Doxorubicin—stomach cancer	4.59e-05	0.00022	CcSEcCtD
Lansoprazole—Anaphylactic shock—Doxorubicin—stomach cancer	4.59e-05	0.00022	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Methotrexate—stomach cancer	4.58e-05	0.000219	CcSEcCtD
Lansoprazole—Fatigue—Methotrexate—stomach cancer	4.57e-05	0.000219	CcSEcCtD
Lansoprazole—Infection—Doxorubicin—stomach cancer	4.56e-05	0.000218	CcSEcCtD
Lansoprazole—Pain—Methotrexate—stomach cancer	4.54e-05	0.000217	CcSEcCtD
Lansoprazole—Vomiting—Capecitabine—stomach cancer	4.53e-05	0.000217	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Epirubicin—stomach cancer	4.52e-05	0.000217	CcSEcCtD
Lansoprazole—Shock—Doxorubicin—stomach cancer	4.52e-05	0.000216	CcSEcCtD
Lansoprazole—Nervous system disorder—Doxorubicin—stomach cancer	4.5e-05	0.000216	CcSEcCtD
Lansoprazole—Thrombocytopenia—Doxorubicin—stomach cancer	4.5e-05	0.000215	CcSEcCtD
Lansoprazole—Rash—Capecitabine—stomach cancer	4.49e-05	0.000215	CcSEcCtD
Lansoprazole—Insomnia—Epirubicin—stomach cancer	4.49e-05	0.000215	CcSEcCtD
Lansoprazole—Dermatitis—Capecitabine—stomach cancer	4.49e-05	0.000215	CcSEcCtD
Lansoprazole—Tachycardia—Doxorubicin—stomach cancer	4.48e-05	0.000215	CcSEcCtD
Lansoprazole—Headache—Capecitabine—stomach cancer	4.46e-05	0.000214	CcSEcCtD
Lansoprazole—Skin disorder—Doxorubicin—stomach cancer	4.46e-05	0.000214	CcSEcCtD
Lansoprazole—Paraesthesia—Epirubicin—stomach cancer	4.46e-05	0.000213	CcSEcCtD
Lansoprazole—Hyperhidrosis—Doxorubicin—stomach cancer	4.44e-05	0.000213	CcSEcCtD
Lansoprazole—Dyspnoea—Epirubicin—stomach cancer	4.43e-05	0.000212	CcSEcCtD
Lansoprazole—Somnolence—Epirubicin—stomach cancer	4.41e-05	0.000211	CcSEcCtD
Lansoprazole—Anorexia—Doxorubicin—stomach cancer	4.38e-05	0.00021	CcSEcCtD
Lansoprazole—Nausea—Docetaxel—stomach cancer	4.37e-05	0.000209	CcSEcCtD
Lansoprazole—Feeling abnormal—Methotrexate—stomach cancer	4.37e-05	0.000209	CcSEcCtD
Lansoprazole—Dyspepsia—Epirubicin—stomach cancer	4.37e-05	0.000209	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Methotrexate—stomach cancer	4.34e-05	0.000208	CcSEcCtD
Lansoprazole—Decreased appetite—Epirubicin—stomach cancer	4.32e-05	0.000207	CcSEcCtD
Lansoprazole—Hypotension—Doxorubicin—stomach cancer	4.29e-05	0.000206	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Epirubicin—stomach cancer	4.29e-05	0.000205	CcSEcCtD
Lansoprazole—Fatigue—Epirubicin—stomach cancer	4.28e-05	0.000205	CcSEcCtD
Lansoprazole—Pain—Epirubicin—stomach cancer	4.24e-05	0.000203	CcSEcCtD
Lansoprazole—Constipation—Epirubicin—stomach cancer	4.24e-05	0.000203	CcSEcCtD
Lansoprazole—Nausea—Capecitabine—stomach cancer	4.23e-05	0.000203	CcSEcCtD
Lansoprazole—Urticaria—Methotrexate—stomach cancer	4.21e-05	0.000202	CcSEcCtD
Lansoprazole—Body temperature increased—Methotrexate—stomach cancer	4.19e-05	0.000201	CcSEcCtD
Lansoprazole—Abdominal pain—Methotrexate—stomach cancer	4.19e-05	0.000201	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Doxorubicin—stomach cancer	4.18e-05	0.0002	CcSEcCtD
Lansoprazole—Insomnia—Doxorubicin—stomach cancer	4.15e-05	0.000199	CcSEcCtD
Lansoprazole—Paraesthesia—Doxorubicin—stomach cancer	4.12e-05	0.000197	CcSEcCtD
Lansoprazole—Dyspnoea—Doxorubicin—stomach cancer	4.09e-05	0.000196	CcSEcCtD
Lansoprazole—Feeling abnormal—Epirubicin—stomach cancer	4.09e-05	0.000196	CcSEcCtD
Lansoprazole—Somnolence—Doxorubicin—stomach cancer	4.08e-05	0.000196	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Epirubicin—stomach cancer	4.06e-05	0.000194	CcSEcCtD
Lansoprazole—Dyspepsia—Doxorubicin—stomach cancer	4.04e-05	0.000194	CcSEcCtD
Lansoprazole—Decreased appetite—Doxorubicin—stomach cancer	3.99e-05	0.000191	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Doxorubicin—stomach cancer	3.97e-05	0.00019	CcSEcCtD
Lansoprazole—Fatigue—Doxorubicin—stomach cancer	3.96e-05	0.00019	CcSEcCtD
Lansoprazole—Urticaria—Epirubicin—stomach cancer	3.94e-05	0.000189	CcSEcCtD
Lansoprazole—Pain—Doxorubicin—stomach cancer	3.93e-05	0.000188	CcSEcCtD
Lansoprazole—Constipation—Doxorubicin—stomach cancer	3.93e-05	0.000188	CcSEcCtD
Lansoprazole—Abdominal pain—Epirubicin—stomach cancer	3.92e-05	0.000188	CcSEcCtD
Lansoprazole—Body temperature increased—Epirubicin—stomach cancer	3.92e-05	0.000188	CcSEcCtD
Lansoprazole—Hypersensitivity—Methotrexate—stomach cancer	3.91e-05	0.000187	CcSEcCtD
Lansoprazole—Asthenia—Methotrexate—stomach cancer	3.81e-05	0.000182	CcSEcCtD
Lansoprazole—Feeling abnormal—Doxorubicin—stomach cancer	3.78e-05	0.000181	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Doxorubicin—stomach cancer	3.76e-05	0.00018	CcSEcCtD
Lansoprazole—Pruritus—Methotrexate—stomach cancer	3.75e-05	0.00018	CcSEcCtD
Lansoprazole—Hypersensitivity—Epirubicin—stomach cancer	3.66e-05	0.000175	CcSEcCtD
Lansoprazole—Urticaria—Doxorubicin—stomach cancer	3.65e-05	0.000175	CcSEcCtD
Lansoprazole—Abdominal pain—Doxorubicin—stomach cancer	3.63e-05	0.000174	CcSEcCtD
Lansoprazole—Body temperature increased—Doxorubicin—stomach cancer	3.63e-05	0.000174	CcSEcCtD
Lansoprazole—Diarrhoea—Methotrexate—stomach cancer	3.63e-05	0.000174	CcSEcCtD
Lansoprazole—Asthenia—Epirubicin—stomach cancer	3.56e-05	0.000171	CcSEcCtD
Lansoprazole—Pruritus—Epirubicin—stomach cancer	3.51e-05	0.000168	CcSEcCtD
Lansoprazole—Dizziness—Methotrexate—stomach cancer	3.51e-05	0.000168	CcSEcCtD
Lansoprazole—Diarrhoea—Epirubicin—stomach cancer	3.4e-05	0.000163	CcSEcCtD
Lansoprazole—Hypersensitivity—Doxorubicin—stomach cancer	3.38e-05	0.000162	CcSEcCtD
Lansoprazole—Vomiting—Methotrexate—stomach cancer	3.37e-05	0.000161	CcSEcCtD
Lansoprazole—Rash—Methotrexate—stomach cancer	3.34e-05	0.00016	CcSEcCtD
Lansoprazole—Dermatitis—Methotrexate—stomach cancer	3.34e-05	0.00016	CcSEcCtD
Lansoprazole—Headache—Methotrexate—stomach cancer	3.32e-05	0.000159	CcSEcCtD
Lansoprazole—Asthenia—Doxorubicin—stomach cancer	3.3e-05	0.000158	CcSEcCtD
Lansoprazole—Dizziness—Epirubicin—stomach cancer	3.28e-05	0.000157	CcSEcCtD
Lansoprazole—Pruritus—Doxorubicin—stomach cancer	3.25e-05	0.000156	CcSEcCtD
Lansoprazole—Vomiting—Epirubicin—stomach cancer	3.16e-05	0.000151	CcSEcCtD
Lansoprazole—Nausea—Methotrexate—stomach cancer	3.15e-05	0.000151	CcSEcCtD
Lansoprazole—Diarrhoea—Doxorubicin—stomach cancer	3.14e-05	0.00015	CcSEcCtD
Lansoprazole—Rash—Epirubicin—stomach cancer	3.13e-05	0.00015	CcSEcCtD
Lansoprazole—Dermatitis—Epirubicin—stomach cancer	3.13e-05	0.00015	CcSEcCtD
Lansoprazole—Headache—Epirubicin—stomach cancer	3.11e-05	0.000149	CcSEcCtD
Lansoprazole—Dizziness—Doxorubicin—stomach cancer	3.04e-05	0.000145	CcSEcCtD
Lansoprazole—Nausea—Epirubicin—stomach cancer	2.95e-05	0.000141	CcSEcCtD
Lansoprazole—Vomiting—Doxorubicin—stomach cancer	2.92e-05	0.00014	CcSEcCtD
Lansoprazole—Rash—Doxorubicin—stomach cancer	2.9e-05	0.000139	CcSEcCtD
Lansoprazole—Dermatitis—Doxorubicin—stomach cancer	2.89e-05	0.000139	CcSEcCtD
Lansoprazole—Headache—Doxorubicin—stomach cancer	2.88e-05	0.000138	CcSEcCtD
Lansoprazole—Nausea—Doxorubicin—stomach cancer	2.73e-05	0.000131	CcSEcCtD
Lansoprazole—CYP2D6—Metabolism—RORA—stomach cancer	8.64e-06	8.04e-05	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—NOS3—stomach cancer	8.61e-06	8.01e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—CYP2A6—stomach cancer	8.6e-06	8e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—ALDOB—stomach cancer	8.59e-06	7.99e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—NDUFA2—stomach cancer	8.57e-06	7.97e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CA1—stomach cancer	8.57e-06	7.97e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—FBP1—stomach cancer	8.57e-06	7.97e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CKB—stomach cancer	8.57e-06	7.97e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—RORA—stomach cancer	8.56e-06	7.97e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—ERCC2—stomach cancer	8.46e-06	7.87e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PDHA1—stomach cancer	8.41e-06	7.83e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—ECHS1—stomach cancer	8.41e-06	7.83e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—AKR1C3—stomach cancer	8.36e-06	7.78e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	8.3e-06	7.72e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—TYMS—stomach cancer	8.28e-06	7.7e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	8.28e-06	7.7e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	8.25e-06	7.68e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—GSTM1—stomach cancer	8.19e-06	7.62e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—ALOX5—stomach cancer	8.18e-06	7.61e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	8.17e-06	7.6e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—ENO1—stomach cancer	8.15e-06	7.58e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—ALDOB—stomach cancer	8.1e-06	7.53e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PLIN2—stomach cancer	8.05e-06	7.49e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—DPYD—stomach cancer	8.05e-06	7.49e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—ALDOB—stomach cancer	8.03e-06	7.47e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—ALB—stomach cancer	8.02e-06	7.46e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—ALOX5—stomach cancer	7.99e-06	7.43e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	7.98e-06	7.43e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—GSTT1—stomach cancer	7.97e-06	7.42e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—MTHFR—stomach cancer	7.95e-06	7.4e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—FADS1—stomach cancer	7.91e-06	7.36e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—TYMP—stomach cancer	7.91e-06	7.36e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—CYP2A6—stomach cancer	7.88e-06	7.33e-05	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—PTGS2—stomach cancer	7.87e-06	7.32e-05	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—ALB—stomach cancer	7.86e-06	7.32e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—DPYD—stomach cancer	7.86e-06	7.31e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CA2—stomach cancer	7.84e-06	7.29e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—ERCC2—stomach cancer	7.7e-06	7.16e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Transmembrane transport of small molecules—APOA1—stomach cancer	7.68e-06	7.15e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—AKR1C3—stomach cancer	7.67e-06	7.13e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PGAM1—stomach cancer	7.64e-06	7.1e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—NT5E—stomach cancer	7.64e-06	7.1e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	7.57e-06	7.04e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	7.55e-06	7.02e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—ALOX5—stomach cancer	7.53e-06	7e-05	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—NOS3—stomach cancer	7.52e-06	7e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—ENO1—stomach cancer	7.47e-06	6.95e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—ALOX5—stomach cancer	7.46e-06	6.94e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—SREBF2—stomach cancer	7.41e-06	6.89e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—DPYD—stomach cancer	7.4e-06	6.89e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—ALB—stomach cancer	7.35e-06	6.84e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—DPYD—stomach cancer	7.34e-06	6.83e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—CAV1—stomach cancer	7.33e-06	6.82e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—RORA—stomach cancer	7.32e-06	6.81e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—APOA1—stomach cancer	7.32e-06	6.81e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	7.3e-06	6.79e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ALDH7A1—stomach cancer	7.28e-06	6.78e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PLCE1—stomach cancer	7.28e-06	6.78e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—MTHFR—stomach cancer	7.23e-06	6.73e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—CD44—stomach cancer	7.23e-06	6.73e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—GSTT1—stomach cancer	7.12e-06	6.62e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—CYP2A6—stomach cancer	7.04e-06	6.55e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	7.01e-06	6.53e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	7.01e-06	6.52e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—UMPS—stomach cancer	6.98e-06	6.5e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—GSTT1—stomach cancer	6.95e-06	6.46e-05	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—PTGS2—stomach cancer	6.88e-06	6.4e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—CYP2A6—stomach cancer	6.87e-06	6.39e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—ALDOB—stomach cancer	6.86e-06	6.38e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—AKR1C3—stomach cancer	6.84e-06	6.37e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—AKR1C3—stomach cancer	6.68e-06	6.22e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—CAV1—stomach cancer	6.67e-06	6.21e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—ENO1—stomach cancer	6.67e-06	6.21e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—APOA1—stomach cancer	6.66e-06	6.19e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	6.65e-06	6.19e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—CD44—stomach cancer	6.63e-06	6.17e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—ALB—stomach cancer	6.56e-06	6.1e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—GSTT1—stomach cancer	6.55e-06	6.09e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—ENO1—stomach cancer	6.51e-06	6.06e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PDHA1—stomach cancer	6.49e-06	6.04e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ECHS1—stomach cancer	6.49e-06	6.04e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—GSTT1—stomach cancer	6.49e-06	6.04e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—CYP2A6—stomach cancer	6.47e-06	6.02e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	6.47e-06	6.02e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	6.45e-06	6e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—PPARG—stomach cancer	6.45e-06	6e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	6.43e-06	5.98e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—CYP2A6—stomach cancer	6.42e-06	5.97e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—ALOX5—stomach cancer	6.38e-06	5.93e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—AKR1C3—stomach cancer	6.3e-06	5.86e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—DPYD—stomach cancer	6.27e-06	5.84e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—AKR1C3—stomach cancer	6.24e-06	5.81e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PPP2R1A—stomach cancer	6.15e-06	5.72e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—ENO1—stomach cancer	6.14e-06	5.71e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—TYMP—stomach cancer	6.1e-06	5.68e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—FADS1—stomach cancer	6.1e-06	5.68e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Transmembrane transport of small molecules—ALB—stomach cancer	6.09e-06	5.66e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—ENO1—stomach cancer	6.08e-06	5.66e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—GSTP1—stomach cancer	6.03e-06	5.61e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—stomach cancer	5.98e-06	5.57e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—HMOX1—stomach cancer	5.95e-06	5.53e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—CD44—stomach cancer	5.92e-06	5.5e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—PPARG—stomach cancer	5.87e-06	5.46e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—ALB—stomach cancer	5.8e-06	5.39e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—CD44—stomach cancer	5.77e-06	5.37e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	5.74e-06	5.34e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—SREBF2—stomach cancer	5.72e-06	5.32e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	5.69e-06	5.29e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—RORA—stomach cancer	5.65e-06	5.25e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PPP2R1A—stomach cancer	5.64e-06	5.24e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—TYMS—stomach cancer	5.61e-06	5.21e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—GSTT1—stomach cancer	5.55e-06	5.16e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—NOS3—stomach cancer	5.55e-06	5.16e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—GSTM1—stomach cancer	5.54e-06	5.15e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—GSTP1—stomach cancer	5.53e-06	5.14e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CYP2A6—stomach cancer	5.48e-06	5.1e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—HMOX1—stomach cancer	5.45e-06	5.07e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—CD44—stomach cancer	5.44e-06	5.06e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—CD44—stomach cancer	5.39e-06	5.02e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—AKR1C3—stomach cancer	5.33e-06	4.96e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ALDOB—stomach cancer	5.29e-06	4.92e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—ALB—stomach cancer	5.27e-06	4.91e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	5.23e-06	4.87e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—ERCC2—stomach cancer	5.21e-06	4.85e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—ENO1—stomach cancer	5.2e-06	4.84e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—TYMS—stomach cancer	5.14e-06	4.78e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—stomach cancer	5.11e-06	4.76e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—GSTM1—stomach cancer	5.08e-06	4.73e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—PTGS2—stomach cancer	5.07e-06	4.72e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—NOS3—stomach cancer	5.05e-06	4.69e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PPP2R1A—stomach cancer	5.03e-06	4.68e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—GSTP1—stomach cancer	4.93e-06	4.59e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ALOX5—stomach cancer	4.92e-06	4.58e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PPP2R1A—stomach cancer	4.91e-06	4.57e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—MTHFR—stomach cancer	4.9e-06	4.56e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—HMOX1—stomach cancer	4.87e-06	4.53e-05	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—PIK3CA—stomach cancer	4.84e-06	4.51e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—DPYD—stomach cancer	4.84e-06	4.5e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—GSTP1—stomach cancer	4.82e-06	4.48e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—ERCC2—stomach cancer	4.78e-06	4.44e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—HMOX1—stomach cancer	4.75e-06	4.42e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PPP2R1A—stomach cancer	4.63e-06	4.3e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—PTGS2—stomach cancer	4.61e-06	4.29e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CD44—stomach cancer	4.61e-06	4.29e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—TYMS—stomach cancer	4.59e-06	4.27e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PPP2R1A—stomach cancer	4.59e-06	4.27e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—GSTP1—stomach cancer	4.54e-06	4.22e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—GSTM1—stomach cancer	4.53e-06	4.22e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—CAV1—stomach cancer	4.52e-06	4.2e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—APOA1—stomach cancer	4.51e-06	4.19e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—GSTP1—stomach cancer	4.5e-06	4.19e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—MTHFR—stomach cancer	4.49e-06	4.18e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—TYMS—stomach cancer	4.48e-06	4.17e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—HMOX1—stomach cancer	4.48e-06	4.16e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	4.47e-06	4.16e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—HMOX1—stomach cancer	4.44e-06	4.13e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—GSTM1—stomach cancer	4.43e-06	4.12e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	4.32e-06	4.01e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GSTT1—stomach cancer	4.28e-06	3.98e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—ERCC2—stomach cancer	4.26e-06	3.97e-05	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—PIK3CA—stomach cancer	4.23e-06	3.94e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CYP2A6—stomach cancer	4.23e-06	3.94e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—TYMS—stomach cancer	4.22e-06	3.92e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—TYMS—stomach cancer	4.18e-06	3.89e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—GSTM1—stomach cancer	4.17e-06	3.88e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—ERCC2—stomach cancer	4.16e-06	3.87e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—CAV1—stomach cancer	4.14e-06	3.85e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—GSTM1—stomach cancer	4.13e-06	3.85e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—APOA1—stomach cancer	4.13e-06	3.84e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—AKR1C3—stomach cancer	4.12e-06	3.83e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ENO1—stomach cancer	4.01e-06	3.73e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—MTHFR—stomach cancer	4.01e-06	3.73e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PPARG—stomach cancer	3.97e-06	3.69e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	3.96e-06	3.68e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—ERCC2—stomach cancer	3.92e-06	3.65e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PPP2R1A—stomach cancer	3.92e-06	3.65e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—MTHFR—stomach cancer	3.91e-06	3.64e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—ERCC2—stomach cancer	3.89e-06	3.62e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—GSTP1—stomach cancer	3.84e-06	3.58e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—HMOX1—stomach cancer	3.79e-06	3.53e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—CAV1—stomach cancer	3.7e-06	3.44e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—APOA1—stomach cancer	3.69e-06	3.43e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—MTHFR—stomach cancer	3.69e-06	3.43e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—MTHFR—stomach cancer	3.65e-06	3.4e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PPARG—stomach cancer	3.64e-06	3.39e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—CAV1—stomach cancer	3.61e-06	3.36e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—APOA1—stomach cancer	3.6e-06	3.35e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—TYMS—stomach cancer	3.57e-06	3.33e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—ALB—stomach cancer	3.57e-06	3.32e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CD44—stomach cancer	3.56e-06	3.31e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—GSTM1—stomach cancer	3.53e-06	3.29e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	3.53e-06	3.29e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—NOS3—stomach cancer	3.42e-06	3.18e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—CAV1—stomach cancer	3.4e-06	3.16e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—APOA1—stomach cancer	3.39e-06	3.16e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—CAV1—stomach cancer	3.37e-06	3.14e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—APOA1—stomach cancer	3.36e-06	3.13e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—ERCC2—stomach cancer	3.32e-06	3.09e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—ALB—stomach cancer	3.27e-06	3.05e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PPARG—stomach cancer	3.25e-06	3.02e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	3.22e-06	3e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PPARG—stomach cancer	3.17e-06	2.95e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—NOS3—stomach cancer	3.13e-06	2.91e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PTGS2—stomach cancer	3.12e-06	2.91e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—MTHFR—stomach cancer	3.12e-06	2.9e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—PIK3CA—stomach cancer	3.12e-06	2.9e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PPP2R1A—stomach cancer	3.02e-06	2.81e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PPARG—stomach cancer	2.99e-06	2.78e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GSTP1—stomach cancer	2.97e-06	2.76e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PPARG—stomach cancer	2.96e-06	2.76e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—HMOX1—stomach cancer	2.93e-06	2.72e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—ALB—stomach cancer	2.92e-06	2.72e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CAV1—stomach cancer	2.88e-06	2.68e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—APOA1—stomach cancer	2.87e-06	2.67e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PTGS2—stomach cancer	2.86e-06	2.66e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—ALB—stomach cancer	2.85e-06	2.65e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—PIK3CA—stomach cancer	2.84e-06	2.64e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—NOS3—stomach cancer	2.79e-06	2.6e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—TYMS—stomach cancer	2.76e-06	2.57e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	2.75e-06	2.56e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—NOS3—stomach cancer	2.73e-06	2.54e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GSTM1—stomach cancer	2.73e-06	2.54e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—ALB—stomach cancer	2.69e-06	2.5e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—ALB—stomach cancer	2.66e-06	2.48e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—NOS3—stomach cancer	2.57e-06	2.39e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ERCC2—stomach cancer	2.56e-06	2.38e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PTGS2—stomach cancer	2.56e-06	2.38e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—NOS3—stomach cancer	2.55e-06	2.37e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PPARG—stomach cancer	2.53e-06	2.36e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PTGS2—stomach cancer	2.49e-06	2.32e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—MTHFR—stomach cancer	2.41e-06	2.24e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PTGS2—stomach cancer	2.35e-06	2.19e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PTGS2—stomach cancer	2.33e-06	2.17e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—ALB—stomach cancer	2.28e-06	2.12e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CAV1—stomach cancer	2.22e-06	2.07e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—APOA1—stomach cancer	2.22e-06	2.06e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—NOS3—stomach cancer	2.18e-06	2.03e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PTGS2—stomach cancer	1.99e-06	1.85e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PPARG—stomach cancer	1.95e-06	1.82e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PIK3CA—stomach cancer	1.92e-06	1.79e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PIK3CA—stomach cancer	1.76e-06	1.64e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ALB—stomach cancer	1.76e-06	1.63e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—NOS3—stomach cancer	1.68e-06	1.56e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PIK3CA—stomach cancer	1.57e-06	1.46e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PTGS2—stomach cancer	1.54e-06	1.43e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PIK3CA—stomach cancer	1.53e-06	1.43e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PIK3CA—stomach cancer	1.45e-06	1.35e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PIK3CA—stomach cancer	1.43e-06	1.33e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PIK3CA—stomach cancer	1.23e-06	1.14e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PIK3CA—stomach cancer	9.46e-07	8.8e-06	CbGpPWpGaD
